UFC women’s strawweight Cynthia Calvillo suffered her first professional setback at UFC 219. Now, she’s got her first professional timeout.

UFC anti-doping partner USADA today announced Calvillo (6-1 MMA, 3-1 UFC) accepted a six-month suspension for testing over the legal limit for marijuana. An in-competition drug test in connection with her losing bout against ex-champ Carla Esparza (13-4 MMA, 4-2 UFC) revealed she came in above the limit of 180 ng/ml for Carboxy-THC, the pharmacologically active metabolite of marijuana.

Calvillo’s suspension began December 30, 2017, though she can reduce it to three months if she successfully completes a USADA-approved drug awareness and management program.

Calvillo is also subject to punishment from the Nevada State Athletic Commission, which regulated UFC 219.

Cannabinoids are considered a specified substance on the WADA prohibited list. They are not banned out-of-competition, however, they are prohibited when an athlete tests above the 180 ng/ml limit.

In 2013, WADA increased the amount of marijuana metabolites allowed in an athlete’s system to 150 ng/ml, a reflection of relaxed attitudes on the plant. This past December, it removed cannabidiol from the list of prohibited substances based on therapeutic applications of the marijuana compound.

Despite the new guidelines, athletes have come in over the new limit. Onetime UFC welterweight title challenger Nick Diaz had double the allowable limit in his system for a fight at UFC 183, which was regulated by the Nevada State Athletic Commission, a regulatory body that follows WADA guidelines on banned substances.

Calvillo must make herself available for random testing during her suspension to receive credit for time completed under their sanction.

For complete coverage of UFC 219, check out the UFC Events section of the site.